Free Trial
→ Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (From Golden Crest) (Ad) Free TVTX Stock Alerts

Travere Therapeutics (TVTX) SEC Filings & 10K Form

Travere Therapeutics logo
$17.72 -0.75 (-4.06%)
(As of 11/15/2024 ET)
Compare

Recent Travere Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
11/14/2024
8:46 AM		Deep Track Capital, LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
11/08/2024
3:55 PM		MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
11/08/2024
3:11 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
11/04/2024
12:55 PM		Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
7:36 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
7:41 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
10/31/2024
7:05 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
10:59 AM		STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
10/04/2024
6:15 PM		LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:38 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:22 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
5:29 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:05 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
9:54 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
9:34 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
9:35 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
8:30 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:24 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form S-3ASR
08/01/2024
3:40 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
3:46 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:05 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:35 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form ARS
03/27/2024
3:31 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form DEF 14A
03/27/2024
3:31 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form DEF 14A
03/27/2024
3:33 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form DEFA14A
02/20/2024
7:10 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
1:35 PM		ARMISTICE CAPITAL, LLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/14/2024
5:38 AM		MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/09/2024
9:33 AM		MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G
02/07/2024
6:37 AM		ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/01/2024
8:57 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:58 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:58 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:58 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
11:44 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s Back, but DC’s Coming for Your Money! (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov
02/01/2024
10:39 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
8:52 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/25/2024
8:24 AM		STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
01/24/2024
8:46 AM		BlackRock Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
01/23/2024
12:17 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
9:51 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
9:52 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
6:07 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:11 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TVTX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
The pin that pops the AI bubble
My new documentary explores the background to this pattern and how and why I believe it will almost certainly ...
Porter & Company | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored